Eton Pharmaceuticals specializes in rare diseases — the stock impresses with relative strength and recently broke out to an all-time high!

Although the pharmaceutical sector has recently come under significant pressure due to new initiatives by the US government, with Trump aiming to reduce high drug prices in the USA causing uncertainty among investors, there are also areas that I suspect will not be affected by these measures, such as rare diseases. In this context, I find the stock of Eton Pharmaceuticals interesting. The company specializes in developing drugs for rare diseases. This year, several medications have already been launched, including Increlex and Galzin. The latter...